Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Innovation Center (FIC) – South is a unique business incubation and economic development accelerator program, which provides business and technology expertise to small and mid-sized food and agribusinesses in
-
as a critical center for advancing biomedical discovery. RITMS bridges the divide between laboratory research and clinical care, accelerating the development of safer, more effective therapies. With
-
Krieger Klein Alzheimer’s Center: Founded in 2023, the Herbert and Jacqueline Krieger Klein Alzheimer’s Center: is fully dedicated to accelerating the discovery of new treatments for Alzheimer’s and related
-
to the outstanding oncology care each person deserves. MISSION: Our mission is to accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention
-
access to the outstanding oncology care each person deserves. MISSION: Our mission is to accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer
-
Policy Research (CUPR) seeks a Postdoctoral Associate to support externally funded projects aimed at accelerating building and grid decarbonization for a sustainable energy transition. CUPR has multiple
-
deserves. MISSION: Our mission is to accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and
-
for Clinical and Translational Science, serves as a critical center for advancing biomedical discovery. RITMS bridges the divide between laboratory research and clinical care, accelerating the development
-
care each person deserves. MISSION: Our mission is to accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding
-
the question of how the oral, lung, and gut microbiomes may contribute to inflammation and lung damage and why people with HIV get accelerated lung disease using human samples, organoid models, and ex vivo